CRYOPORT INC

NASDAQ: CYRX (CryoPort, Inc.)

Last update: 13 hours ago

19.05

-0.50 (-2.56%)

Previous Close 19.55
Volume 814,782
Avg. Volume (3M) 843,800
Market Cap 964,865,344
Price / Earnings (Forward) 73.27
Price / Sales 4.97
Price / Book 2.22
52 Weeks Range
7.61 (-60%) — 21.78 (14%)
Earnings Date 5 Nov 2026
Profit Margin -21.46%
Operating Margin (TTM) -14.40%
Diluted EPS (TTM) -0.900
Quarterly Revenue Growth (YOY) 13.50%
Total Debt/Equity (MRQ) 47.88%
Current Ratio (MRQ) 2.04
Operating Cash Flow (TTM) 11.00 M
Levered Free Cash Flow (TTM) -10.91 M
Return on Assets (TTM) -2.27%
Return on Equity (TTM) -7.44%

AIStockmoo Score

0.2
Earns below its cost of capital. Returns on capital falling. info
Low debt. Weak profitability. Ample short-term liquidity. Negative cash flow. info
From our AI Insight report's view of expected return against risk. info NA
Relative Valuation info NA
Implied Growth info NA
Valuation History info NA
Holdings' Value info NA
Risk Premium info NA
Market Valuation info NA
Uptrend over the past year. Trading near its 52-week high. info
In an uptrend: the price is above its moving averages, and they are rising. It is close to them. info
From our AI technical analysis of the chart. info NA
Candle Patterns info NA
No recent price targets, so based on how targets have been revised. info
Recent news mostly positive. info
Holdings' Sentiment info NA
Insiders net selling recently. info
Institutions net +2.15% of shares in their latest 13F filings: 94 holders increased, 89 decreased (quarter to 30 Sep 2026). info
Short interest +28.1% from 31 Aug to 30 Oct 2026, 4.1 days to cover (FINRA). info
Market environment cautious. info
Sector lagging the market.
The pillars disagree, so the score is softened.
Earnings per share have gone up and down. Made a loss in recent years. info
Above its medium-term trend line. info
Price is high against its 52-week average. Down over 5 years. info
Trend up on all three terms. Short-term momentum rising. info
Price is near resistance. info
Final Score 0.22
Show all

Market Trend

Short Term Medium Term
Industry Integrated Freight & Logistics (US) Mixed Bullish
Integrated Freight & Logistics (Global) Mixed Bullish
Stock CryoPort, Inc. Mixed Bearish

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B Score
CYRX 965 M - - 2.22 0.2
FWRD 549 M - - 5.97 -1.0
SFWL 27 M - 2.25 0.190 -1.3
SLGB 6 M - - 0.390 -2.8
SGLY 2 M - 0.034 0.040 -2.2
CTNT - - - 0.030 -2.3

Select this tab to load the latest available analysis.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Sector Industrials
Industry Integrated Freight & Logistics
Investment Style Small Value
% Held by Insiders 3.83%
% Held by Institutions 95.21%

Ownership

Name Date Shares Held
Cadian Capital Management, Lp 30 Sep 2026 2,418,947
Fred Alger Management, Llc 30 Sep 2026 1,690,723
Mak Capital One Llc 30 Sep 2026 1,074,631
Silvercrest Asset Management Group Llc 30 Sep 2026 781,741
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
HANCOCK DANIEL M - 20.47 -74,379 -1,522,538
SAWICKI MARK W - 20.74 -10,000 -207,400
Aggregate Net Quantity -84,379
Aggregate Net Value ($) -1,729,938
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 20.50
Name Holder Date Type Quantity Price Value ($)
SAWICKI MARK W Officer 10 Nov 2026 Sell (-) 10,000 20.74 207,400
HANCOCK DANIEL M Director 09 Nov 2026 Sell (-) 74,379 20.47 1,522,538
HANCOCK DANIEL M Director 09 Nov 2026 Option execute 74,379 - -

Institutions

Institutional ownership: 95.44%

Positions Holders Shares
Increased 94 5,218,816
Decreased 89 4,937,196
New 30 1,449,620
Sold out 18 632,376

SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.

Short Interest

Settlement Shares Days to cover
30 Oct 2026 3,477,459 4.1
15 Oct 2026 2,532,755 3.1
30 Sep 2026 2,362,636 3.4
15 Sep 2026 2,786,514 5.8
31 Aug 2026 2,713,665 4.9
14 Aug 2026 2,515,480 4.6

FINRA short interest via Nasdaq, reported twice a month.

3 Positive 1 Negative 0 Neutral
Date Type Details
13 Nov 2026 Yahoo Finance Cryoport (CYRX) Stock Looks Fully Priced Following Its 129% Rebound
Cryoport has delivered a sharp rebound in its share price, which naturally puts the focus on whether the current valuation can be grounded in its sales rather than just recent momentum. With a stock that has moved this far, this fast, the question is how well the revenue base supports where the…
12 Nov 2026 Yahoo Finance Does Raised Revenue Guidance Change The Bull Case For Cryoport (CYRX)?
Cryoport reported third quarter 2026 revenue of US$50.22 million compared to US$44.23 million a year earlier, with a wider net loss of US$10.85 million and basic loss per share of US$0.25. The business lifted full year 2026 revenue guidance to a range of US$197 million to US$199 million…
10 Nov 2026 Yahoo Finance Why Cryoport (CYRX) Shares Climbed After Its Latest Update?
Cryoport (CYRX) has become a talking point after its third quarter 2026 report, which paired higher revenue with a wider loss and an increase in full year sales guidance to US$197 million to US$199 million. The guidance hike has landed in a market that was already re-rating Cryoport, with the share…
09 Nov 2026 Yahoo Finance What Comes Next For Cryoport After A 100% Gain
If Cryoport was on your watchlist rather than in your portfolio over 2026, the outcome may feel like a missed shot. For Cryoport shareholders, the return from the start of the year was 99.8%, including dividends. That kind of move invites a hard question. Back on 1 January, when analysts were split…
06 Nov 2026 Yahoo Finance Cryoport, Inc. Q3 2026 Earnings Call Summary
Moby summary of Cryoport, Inc.'s Q3 2026 earnings call…
06 Nov 2026 Yahoo Finance Cryoport (CYRX) Q3 2026 Earnings Call Transcript
Services growth and a raised outlook headline a strong cell therapy logistics quarter.
06 Nov 2026 Yahoo Finance CryoPort Inc (CYRX) (Q3 2026) Earnings Call Highlights: Record Clinical Pipeline and Positive ...
CryoPort Inc (CYRX) lifted its full-year 2026 revenue outlook to $197-$199 million after posting 14% growth and a second straight quarter of positive adjusted EBITDA.
06 Nov 2026 Yahoo Finance CryoPort Q3 Earnings Call Highlights
CryoPort (NASDAQ:CYRX) raised its full-year 2026 revenue outlook after reporting third-quarter revenue growth of 14%, supported by demand for its cell and gene therapy services and cryogenic products. The company reported revenue of $50.2 million and adjusted earnings before interest, taxes, deprec…
05 Nov 2026 Yahoo Finance CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
CryoPort (CYRX) delivered earnings and revenue surprises of -31.58% and +3.16%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
05 Nov 2026 Yahoo Finance Cryoport Reports Third Quarter 2026 Financial Results
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced financial results for its third quarter (Q3) and first nine months (9M) of 2026…
04 Nov 2026 Yahoo Finance Cencora (COR) Surpasses Q4 Earnings and Revenue Estimates
Cencora (COR) delivered earnings and revenue surprises of +2.19% and +0.22%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
22 Oct 2026 Yahoo Finance Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the third quarter ended September 30, 2026 on Thursday…
01 Oct 2026 Yahoo Finance Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.
24 Aug 2026 Yahoo Finance Cryoport (CYRX) Stock Fair Value Rises After Analysts Lift Growth Assumptions
The latest analyst work on Cryoport points to a higher blended fair value estimate, with price targets moving from US$17.06 to US$19.33, about a 13% uplift in the modeled target level. That shift lines up with more constructive Street commentary, as several bullish analysts highlight Cryoport’s…
Show more

Technical Setup Medium

Trend order
Slope
Entry
Volume
In an uptrend: the price is above its moving averages, and they are rising. It is close to them.
Nearest support: 18.47 – 19.14 · moderate level
Nearest resistance: 19.16 – 19.68 · moderate level

AI Technical Analysis

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Risk / Reward
TP1:
TP2:

Loss to SL against profit to each target, from EP. A ratio of 2 or more is usually sought.

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria